| FICWX | HBLCX | FICWX / HBLCX | |
| Total Expense Ratio | 0.30 | 1.64 | 18% |
| Annual Report Gross Expense Ratio | 0.30 | 1.64 | 18% |
| Fund Existence | 9 years | 19 years | - |
| Gain YTD | 12.026 | 8.895 | 135% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 2000 | 50,000% |
| Min. Initial Investment IRA | N/A | 2000 | - |
| Net Assets | 1.36B | 11.7B | 12% |
| Annual Yield % from dividends | 3.38 | 2.59 | 131% |
| Returns for 1 year | 11.18 | 2.86 | 391% |
| Returns for 3 years | 29.37 | 15.73 | 187% |
| Returns for 5 years | 24.75 | 9.86 | 251% |
| Returns for 10 years | N/A | 37.03 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GAA | 32.32 | 0.19 | +0.58% |
| Cambria Global Asset Allocation ETF | |||
| SEPW | 31.63 | 0.02 | +0.07% |
| AllianzIM U.S. Large Cp Buffer20 Sep ETF | |||
| CPSF | 25.32 | N/A | N/A |
| Calamos S&P 500 Str Alt Prt ETF-Feb | |||
| PBDE | 29.10 | N/A | N/A |
| PGIM S&P 500 Buffer 20 ETF - Dec | |||
| ARKG | 28.30 | -0.51 | -1.77% |
| ARK Genomic Revolution ETF | |||